| Date Filed | Type | Description |
| 11/16/2020 |
4
| Sullivan Ryan T (General Counsel and Secretary) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 493 shares
@ $37.87, valued at
$18.7k
|
|
| 08/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/14/2020 |
4
| Sullivan Ryan T (General Counsel and Secretary) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 493 shares
@ $85.08, valued at
$41.9k
|
|
| 02/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2020 |
4
| Sullivan Ryan T (General Counsel and Secretary) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Granted 5,600 shares
@ $0
Granted 9,200 options to buy
@ $99.66, valued at
$916.9k
|
|
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/15/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/14/2019 |
4
| Sullivan Ryan T (General Counsel and Secretary) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 689 shares
@ $66.03, valued at
$45.5k
|
|
| 05/14/2019 |
4
| Sullivan Ryan T (General Counsel and Secretary) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 711 shares
@ $83.73, valued at
$59.5k
|
|
| 02/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2019 |
4
| Sullivan Ryan T (General Counsel and Secretary) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Granted 6,600 shares
@ $0
Granted 10,700 options to buy
@ $110.8, valued at
$1.2M
|
|
| 02/15/2018 |
4
| Sullivan Ryan T (General Counsel) has filed a Form 4 on INTERCEPT PHARMACEUTICALS INC|
Txns:
| Granted 23,200 shares
@ $0
Granted 35,300 options to buy
@ $53.41, valued at
$1.9M
|
|
| 02/15/2018 |
3
| Sullivan Ryan T (General Counsel) has filed a Form 3 on INTERCEPT PHARMACEUTICALS INC |
| 06/24/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/29/2016 |
4
| Sullivan Ryan T (EVP and General Counsel) has filed a Form 4 on Anacor Pharmaceuticals, Inc.|
Txns:
| Sold 3,125 shares
@ $66.33, valued at
$207.3k
|
|
| 02/05/2016 |
4
| Sullivan Ryan T (EVP and General Counsel) has filed a Form 4 on Anacor Pharmaceuticals, Inc.|
Txns:
| Granted 6,250 shares
@ $0
Granted 31,623 options to buy
@ $78.91, valued at
$2.5M
Granted 6,250 options to buy
@ $0 |
|
| 10/01/2013 |
4
| Sullivan Ryan T (VP, General Counsel & Secr.) has filed a Form 4 on Warner Chilcott plc|
Txns:
| Disposed/sold 8,420 shares
@ $0
Disposed/sold 18,040 shares
@ $0
Disposed/sold 8,170 options to buy
@ $0
Disposed/sold 2,193 options to buy
@ $2.02, valued at
$4.4k
Disposed/sold 1,065 options to buy
@ $1.88, valued at
$2k
Disposed/sold 6,610 options to buy
@ $16.06, valued at
$106.2k
Disposed/sold 8,990 options to buy
@ $21.49, valued at
$193.2k
Disposed/sold 15,730 options to buy
@ $13.35, valued at
$210k
Disposed/sold 28,860 options to buy
@ $14.31, valued at
$413k
|
|
| 06/10/2013 |
3
| Sullivan Ryan T (VP, General Counsel & Secr.) has filed a Form 3 on Warner Chilcott plc |